SHL Telemedicine Ltd. engages in the development and market of advanced personal telemedicine solutions, which focuses on cardiovascular and related diseases. Personal telemedicine is the transmission of medical data by an individual, from a remote location, to a medical call center through telecommunication networks. SHL’s platform offers solutions to subscribing patients, health insurance companies, hospitals, clinics, physicians and other health care providers. Its solutions for healthcare professionals include: CHF monitoring service that supports patients suffering from Congestive Heart Failure; COPD monitoring service that supports patients suffering from Chronic Obstructive Pulmonary Disease, and Readmission Solutions for reducing heart-related readmissions. Its consumers' solutions include Cardiac Monitoring Service.
Follow-Up Questions
What is the price performance of SHMLF stock?
The current price of SHMLF is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for SHL Telemedicine Ltd?
SHL Telemedicine Ltd belongs to Health Care industry and the sector is Health Care
